Mensinger Mike
Beta Bionics, Inc. · Chief Product Officer
Mensinger Mike is listed in filings as Chief Product Officer at Beta Bionics, Inc.. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Beta Bionics, Inc. (BBNX). The current snapshot covers public activity from Jun 4, 2025 to Jun 3, 2026. Reported amounts are shown as $55.2K to $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $13k1.1k shares | SellMar 2, 2026 | $12.36 | $11.63 | |
| $66k2.2k shares | SellJan 6, 2026 | $30.10 | $11.63 | |
| $213k7.2k shares | SellJan 2, 2026 | $29.56 | $11.63 | |
| $18k600 shares | SellJan 2, 2026 | $30.20 | $11.63 | |
| $31k1.1k shares | SellDec 2, 2025 | $29.34 | $11.63 | |
| $21k1.1k shares | SellSep 2, 2025 | $18.86 | $11.63 | |
| $1.9k101 shares | SellJun 2, 2025 | $18.69 | $11.63 | |
| $13k708 shares | SellJun 2, 2025 | $18.15 | $11.63 | |
| $5.2k306 shares | SellJun 2, 2025 | $17.03 | $11.63 |